Ambien doses are too high, according to FDA - - Jackson, MS

Ambien doses are too high, according to FDA

Posted: Updated:
JACKSON, MS (Mississippi News Now) -

The FDA has issued a new warning about popular sleep drugs after studies show they don't leave your system as quickly as previously thought.

New data from driving simulations and blood tests show sleep drugs like Ambien, Ambien CR, Edluar and Zolpimist can still be active the morning after use, and driving could be impaired.

Women appear to be particularly affected because they metabolize the drug slower than men.

Experts are recommending the dose be cut in half for women and men should consider using a lower dose.

They say this will ensure less of the drug is present in the blood in the morning.

FDA officials say patients should not change the dose on their own, rather they should talk to their doctor first.

The FDA has informed the manufacturers that the recommended dosage of zolpidem for women should be lowered from 10 milligrams (mg) to 5 mg for immediate-release products (Ambien, Edluar, and Zolpimist) and from 12.5 mg to 6.25 mg for extended-release products (Ambien CR).

For men, the FDA has informed the manufacturers that the labeling should recommend that health care professionals consider prescribing these lower doses (5 mg for immediate-release products and 6.25 mg for extended-release products).

These products are currently available on the market in both the higher and lower dosages.

Copyright 2012 MSNewsNow. All rights reserved.

Powered by WorldNow